Resistant and relapsing neuroblastoma: improved response rate with a new multiagent regimen (OC-HDP) including high-dose cisplatinum.

Source:http://linkedlifedata.com/resource/pubmed/id/3561328

Download in:

View as

General Info

PMID
3561328